Omnicare ends PharMerica takeover attempt, posts 4Q profit

Leading long-term care pharmacy provider Omnicare, which announced this week that it has ended its efforts to takeover competitor PharMerica, posted a profit in the fourth quarter.

Faced with the Federal Trade Commission's lawsuit blocking the takeover of PharMerica, Omnicare said Tuesday it was no longer “prudent to invest significant time and money in a lawsuit at this time.” The FTC voted Thursday to dismiss its lawsuit.

Omnicare first made a play for PharMerica in September, when it went public with a $457 million offer, which its biggest rival rebuffed.

Despite the loss, Omnicare stakeholders had good news yesterday, when the company announced it earned $31.2 million ending in December, compared to a loss of $65.3 million in the same quarter last year, the Associated Press reported. Revenue went up 2% to $1.56 billion from $1.53 billion. In 2012, the company said it expects to have an adjusted profit of $3.10 to $3.20 per share from continuing operations, and revenue between $6.1 billion and $6.2 billion.

More in News

Provider groups protest MedPAC recommendations to reduce therapy caps

Provider groups protest MedPAC recommendations to reduce therapy ...

Resident care would suffer and providers would shoulder a larger burden if Congress acts on the latest recommendations from the Medicare Payment Advisory Commission, advocates for the long-term care sector ...

Tight timeline forces LTC commission to narrow its ambitions, member says

With its report due by the end of September, the Congressional Long-Term Care Commission is setting its sights on what can be accomplished in an "extraordinarily short time-frame," according to member Judith Stein, executive director of the Center for Medicare Advocacy.

HHS proposes rule to improve consistency of long-term care ombudsman programs

The Department of Health and Human Services' Administration on Aging has proposed a rule to create federal guidelines for long-term care ombudsman programs, to create more uniformity and address questions around ombudsman responsibilities, information disclosure, complaint resolution and conflicts of interest.